This inventor holds 2 USPTO granted patents. Top assignee: Rohm Pharma Gmbh. Active years: 1991-1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1991-1992
Title: The Innovations of Karl-Dieter Volger
Introduction
Karl-Dieter Volger is a notable inventor based in Bickenbach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of sleep apnea and hypertension. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Volger's latest patents include a remedy for the treatment of sleep apnea. This innovative treatment involves administering a therapeutically effective amount of 2-isopropyl-2,8-bis(3,4-dimethoxyphenyl)-6-methyl-6-azaoctane nitrile to a subject. Additionally, he has developed a pharmaceutical preparation that possesses both antihypertensive and cardio-protective effects. This preparation comprises a combination of active ingredients, including α-isopropyl-α-[(N-methyl-N-homoveratryl)-γ-aminopropyl]-3,4-dimethoxyphenyl-acetonitrile, 2,4,7-triamino-6-phenyl-pteridine, and 6-chloro-3,4-dihydro-7-sulfamoyl-2H-1,2,4-benzothiadiazine-1,1-dioxide, along with a carrier and auxiliary materials in single dosage form.
Career Highlights
Karl-Dieter Volger is currently associated with Rohm Pharma GmbH, where he continues to innovate in the pharmaceutical sector. His work has garnered attention for its potential therapeutic benefits and contributions to medical science.
Collaborations
Throughout his career, Volger has collaborated with notable colleagues, including Klaus Lossnitzer and Karl-Friedrich Ober. These partnerships have likely enhanced the scope and impact of his inventions.
Conclusion
Karl-Dieter Volger's contributions to the field of pharmaceuticals demonstrate his commitment to improving health outcomes through innovative treatments. His patents reflect a dedication to addressing significant medical challenges, particularly in sleep apnea and hypertension.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile